Exact Mass: 669.1819368
Exact Mass Matches: 669.1819368
Found 22 metabolites which its exact mass value is equals to given mass value 669.1819368
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Chymosin preparation, escherichia coli k-12
C30H27N3O15 (669.1442112000001)
Chymosin preparation, escherichia coli k-12 is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents
N,N,N-tris(2,3-dihydroxybenzoyl)-O-(alpha-aminoacryl)-O-seryl-Serin
C30H27N3O15 (669.1442112000001)
Enterobactin
C30H27N3O15 (669.1442112000001)
A macrotriolide produced by certain members of Enterobacteriaceae, e.g. Escherichia coli and Salmonella. D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents
Almitrine mesylate
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D019141 - Respiratory System Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[2-[(2S,4S)-4-[(2R,3R,4R,5S,6S)-3-fluoro-4,5-dihydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-oxoethyl] 3-aminopropanoate,hydrochloride
C30H33ClFNO13 (669.1624370000001)
Berubicin hydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
Delphinidin 3-glucoside-5-(6-acetylglucoside)
C29H33O18+ (669.1666818000001)
[3,7-bis(4-hydroxy-3,5-dimethoxyphenyl)-4-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-ylidene]oxidanium
5-{[(2s,3r,4s,5s,6s)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-3-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium
[C29H33O18]+ (669.1666818000001)
{3-hydroxy-23,24-dimethoxy-7,7-dimethyl-5,8,18,27,29-pentaoxo-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2,4(12),13,15,19(28),21,23,25-nonaen-10-yl}methyl 3-methylbutanoate
n-[7,11-bis({[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino})-2,6,10-trioxo-1,5,9-trioxacyclododecan-3-yl]-2,3-dihydroxybenzenecarboximidic acid
C30H27N3O15 (669.1442112000001)
n-[(3s,7s,11s)-7,11-bis({[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino})-2,6,10-trioxo-1,5,9-trioxacyclododecan-3-yl]-2,3-dihydroxybenzenecarboximidic acid
C30H27N3O15 (669.1442112000001)